• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

诊断疑似艰难梭菌相关性腹泻患者的三步诊断算法。

Three-step diagnostic algorithm in diagnosing patients suspected of Clostridium difficile-associated diarrhea.

作者信息

Schneider Anna, Mól Anna, Lisowska Katarzyna, Jax-Dambek Maria, Lachowicz Dominika, Obuch-Woszczatyński Piotr, Pituch Hanna

机构信息

Microbiology Clinical Laboratory.

Section for Healthcare-associated Infection Control University Hospital of Lord's Transfiguration in Poznań

出版信息

Przegl Epidemiol. 2014;68(4):669-74.

PMID:25848788
Abstract

UNLABELLED

Clostridium difficile is a predominant etiological agent of healthcare-associated infectious diarrhea. Immunoenzymatic tests for detecting toxins A/B from faecal samples are still used in routine diagnosis of Clostridium difficile-associated diseases in a number of healthcare centers in Poland. Recently, however, new diagnostic tests were introduced which allow for detecting toxigenic strains of C. difficile in a more effective and precise manner. It is of importance, especially in the light of hypervirulent strain occurrence.

AIM

The aim of the present paper was to evaluate the efficacy of three-step algorithm in the diagnosis of Clostridium difficile-associated diseases (CDAD), considering the occurrence of false negative test results for toxins while using exclusively immunoenzymatic tests.

MATERIALS AND METHODS

In the present study, faecal samples collected from patients presenting diarrhea were tested. Immunoenzymatic tests were used for detecting glutamate dehydrogenase (GDH) and toxins A/B. Culture and RT-PCR were also employed.

RESULTS

Of 615 study participants, toxigenic strains GDH (+) TOX (+) were identified in 108 patients while for 67 patients, test results remained unspecified GDH (+) TOX (-). Further analysis of unspecified samples revealed 32 patients infected with toxigenic strains, i.e. 22.9% of all positive test results (n=140).

CONCLUSION

Three-step diagnostic algorithm is an effective and reliable tool for diagnosing C.difficile- associated diseases.

摘要

未标注

艰难梭菌是医疗保健相关感染性腹泻的主要病原体。在波兰的许多医疗中心,用于检测粪便样本中毒素A/B的免疫酶试验仍用于艰难梭菌相关疾病的常规诊断。然而,最近引入了新的诊断试验,能够以更有效和精确的方式检测艰难梭菌的产毒菌株。这一点很重要,尤其是考虑到高毒力菌株的出现。

目的

本文的目的是评估三步算法在艰难梭菌相关疾病(CDAD)诊断中的有效性,同时考虑仅使用免疫酶试验时毒素检测结果出现假阴性的情况。

材料与方法

在本研究中,对腹泻患者采集的粪便样本进行检测。使用免疫酶试验检测谷氨酸脱氢酶(GDH)和毒素A/B。还采用了培养和逆转录聚合酶链反应(RT-PCR)。

结果

在615名研究参与者中,108名患者鉴定出产毒菌株GDH(+)TOX(+),而67名患者的检测结果仍未明确,为GDH(+)TOX(-)。对未明确样本的进一步分析显示,32名患者感染了产毒菌株,即占所有阳性检测结果(n = 140)的22.9%。

结论

三步诊断算法是诊断艰难梭菌相关疾病的有效且可靠的工具。

相似文献

1
Three-step diagnostic algorithm in diagnosing patients suspected of Clostridium difficile-associated diarrhea.诊断疑似艰难梭菌相关性腹泻患者的三步诊断算法。
Przegl Epidemiol. 2014;68(4):669-74.
2
[The use of two-stage algorithm in the diagnosis of patients with low levels of Clostridium difficile toxins A/B in feces confirmed by using enzyme immunoassay].[应用两阶段算法诊断粪便中艰难梭菌毒素A/B水平较低且经酶免疫测定确诊的患者]
Med Dosw Mikrobiol. 2013;65(4):263-8.
3
Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea.TechLab艰难梭菌检测-60酶免疫测定法(EIA)联合艰难梭菌毒素A/B II EIA试剂盒、Triage艰难梭菌检测板免疫测定法及细胞毒素测定法用于诊断艰难梭菌相关性腹泻的性能
J Clin Microbiol. 2004 Oct;42(10):4863-5. doi: 10.1128/JCM.42.10.4863-4865.2004.
4
Performance of TechLab C. DIFF QUIK CHEK and TechLab C. DIFFICILE TOX A/B II for the detection of Clostridium difficile in stool samples.TechLab艰难梭菌快速检测试剂盒和TechLab艰难梭菌毒素A/B II检测试剂盒在粪便样本中检测艰难梭菌的性能。
Diagn Microbiol Infect Dis. 2007 Sep;59(1):33-7. doi: 10.1016/j.diagmicrobio.2007.04.018. Epub 2007 Jul 26.
5
[Investigation of toxin genes of Clostridium difficile strains isolated from hospitalized patients with diarrhoea at Marmara University Hospital].[对从马尔马拉大学医院腹泻住院患者中分离出的艰难梭菌菌株毒素基因的研究]
Mikrobiyol Bul. 2011 Jan;45(1):1-10.
6
[Experience with laboratory diagnosis of Clostridium difficile].[艰难梭菌实验室诊断经验]
Klin Mikrobiol Infekc Lek. 2013 Sep;19(3):91-5.
7
Evaluation of a simultaneous detection kit for the glutamate dehydrogenase antigen and toxin A/B in feces for diagnosis of Clostridium difficile infection.评估粪便中谷氨酸脱氢酶抗原和毒素 A/B 的同时检测试剂盒用于诊断艰难梭菌感染。
J Infect Chemother. 2011 Dec;17(6):807-11. doi: 10.1007/s10156-011-0267-5. Epub 2011 Jul 2.
8
[New methodological advances: algorithm proposal for management of Clostridium difficile infection].[新的方法学进展:艰难梭菌感染管理的算法建议]
Rev Esp Quimioter. 2015 Jun;28(3):157-9.
9
Clinical usefulness of components of the Triage immunoassay, enzyme immunoassay for toxins A and B, and cytotoxin B tissue culture assay for the diagnosis of Clostridium difficile diarrhea.用于艰难梭菌腹泻诊断的分诊免疫测定、毒素A和B酶免疫测定以及细胞毒素B组织培养测定各组分的临床实用性。
Am J Clin Pathol. 2003 Jan;119(1):45-9. doi: 10.1309/U8AT-L52Q-60XY-AVX6.
10
Evaluation of different methods for detection of Clostridium difficile toxins in Poland.波兰不同艰难梭菌毒素检测方法的评估。
Acta Microbiol Pol. 1999;48(4):349-53.